UY26052A1 - Composiciones analgesicas que comprenden compuestos antiepilepticos y metodos para usarlas - Google Patents
Composiciones analgesicas que comprenden compuestos antiepilepticos y metodos para usarlasInfo
- Publication number
- UY26052A1 UY26052A1 UY26052A UY26052A UY26052A1 UY 26052 A1 UY26052 A1 UY 26052A1 UY 26052 A UY26052 A UY 26052A UY 26052 A UY26052 A UY 26052A UY 26052 A1 UY26052 A1 UY 26052A1
- Authority
- UY
- Uruguay
- Prior art keywords
- combinations
- pain
- methods
- compounds
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Combinaciones de compuestos antiepilépticos que demuestran propiedades para aliviar el dolor, con compuestos seleccionados del grupo que consiste en analgésicos, antagonistas del receptor de NMDA, NSAID y combinaciones de las mismas, y composiciones farmaceúticas que las comprenden. Se ha descubierto que la administración de compuestos antiepilépticos que demuestran propiedades que alivian el dolor en estas combinaciones nuevas da como resultado una reducción mejorada en la frecuencia y severidad del dolor. También se cree que estas combinaciones pueden reducir la incidencia de efectos colaterales no deseados en comparación con el uso de dosis más elevada de un tratamiento de un solo agente para lograr un efecto terapéutico similar. La presente invención también está dirigida a métodos para usar cantidades efectivas de las composiciones farmacéuticas nuevas para tratar el dolor en mamíferos. VER REIV.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12373999P | 1999-03-10 | 1999-03-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY26052A1 true UY26052A1 (es) | 2000-08-21 |
Family
ID=22410582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY26052A UY26052A1 (es) | 1999-03-10 | 2000-03-08 | Composiciones analgesicas que comprenden compuestos antiepilepticos y metodos para usarlas |
Country Status (11)
Country | Link |
---|---|
US (1) | US6451857B1 (es) |
EP (1) | EP1161263A1 (es) |
JP (1) | JP2002538221A (es) |
AR (1) | AR022723A1 (es) |
AU (1) | AU3216600A (es) |
BR (1) | BR0008847A (es) |
CA (1) | CA2359485A1 (es) |
CO (1) | CO5150189A1 (es) |
PE (1) | PE20001558A1 (es) |
UY (1) | UY26052A1 (es) |
WO (1) | WO2000053225A1 (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998003167A1 (en) | 1996-07-24 | 1998-01-29 | Warner-Lambert Company | Isobutylgaba and its derivatives for the treatment of pain |
ATE311867T1 (de) | 1997-09-08 | 2005-12-15 | Warner Lambert Co | Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen |
CA2373953A1 (en) * | 1999-07-02 | 2001-01-11 | Warner-Lambert Company | A synergistic combination: gabapentin and pregabalin |
ZA200108038B (en) * | 2000-10-02 | 2003-04-01 | Pfizer Prod Inc | Prophylactic use of n-methyl-d-asparrate (NMDA) antagonists. |
US8309570B2 (en) | 2001-06-07 | 2012-11-13 | Analgesic Neuropharmaceuticals, Llc | Treatment of central neuropathic pain |
MXPA04002009A (es) | 2001-09-03 | 2004-07-08 | Newron Pharm Spa | Composicion farmaceutica que comprende gabapentina o un analogo de la misma y alfa-aminoamida y su uso como analgesico. |
TWI312285B (en) | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
US7612112B2 (en) | 2001-10-25 | 2009-11-03 | Depomed, Inc. | Methods of treatment using a gastric retained gabapentin dosage |
US6730667B2 (en) * | 2001-11-26 | 2004-05-04 | William R. Deagle | Iontophoresis disc pain blocker |
CA2473536A1 (en) * | 2002-01-16 | 2003-07-31 | Endo Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating disorders of the central nervous system |
JP4428053B2 (ja) * | 2002-02-05 | 2010-03-10 | 味の素株式会社 | ガバペンチン若しくはプレガバリンおよびn型カルシウムチャンネル拮抗剤を含有する医薬組成物 |
RU2286151C2 (ru) * | 2002-02-22 | 2006-10-27 | Уорнер-Ламберт Компани Ллс | Комбинации альфа-2-дельта-лиганда с селективным ингибитором циклооксигеназы-2 |
US7799832B2 (en) | 2003-10-23 | 2010-09-21 | Valeant Pharmaceuticals North America | Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
FR2862875B1 (fr) * | 2003-12-02 | 2006-04-07 | Mathey Acoustique Service | Preparation pharmaceutique pour le traitement des acouphenes |
WO2005102390A2 (en) * | 2004-04-22 | 2005-11-03 | Pfizer Japan, Inc. | Combinations comprising alpha-2-delta ligands and nmda receptor antagonists |
ES2556937T3 (es) | 2005-12-22 | 2016-01-21 | Newron Pharmaceuticals S.P.A. | Derivados de 2-feniletilamino como moduladores de los canales de calcio y/o sodio |
US20090176882A1 (en) | 2008-12-09 | 2009-07-09 | Depomed, Inc. | Gastric retentive gabapentin dosage forms and methods for using same |
US7960436B2 (en) * | 2006-06-05 | 2011-06-14 | Valeant Pharmaceuticals International | Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators |
SG174095A1 (en) * | 2006-08-23 | 2011-09-29 | Valeant Pharmaceuticals Int | Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
US8993593B2 (en) * | 2006-08-23 | 2015-03-31 | Valeant Pharmaceuticals International | N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators |
US8722929B2 (en) * | 2006-10-10 | 2014-05-13 | Valeant Pharmaceuticals International | N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators |
BRPI0719590A2 (pt) * | 2006-11-28 | 2014-01-21 | Valeant Pharmaceuticals Int | Análogos de retigabina 1,4 diamino bicíclica como modulares de canal de potássio |
MX2009006575A (es) * | 2006-12-22 | 2009-07-02 | Recordati Ireland Ltd | Terapia de combinacion de trastornos del tracto urinario inferior con ligandos a2d y farmacos anti-inflamatorios no esteroidales (nsaids). |
US8367684B2 (en) * | 2007-06-13 | 2013-02-05 | Valeant Pharmaceuticals International | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
US8563566B2 (en) * | 2007-08-01 | 2013-10-22 | Valeant Pharmaceuticals International | Naphthyridine derivatives as potassium channel modulators |
US7786146B2 (en) * | 2007-08-13 | 2010-08-31 | Valeant Pharmaceuticals International | Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
EP2116539A1 (en) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof |
JP2010043063A (ja) | 2008-05-09 | 2010-02-25 | Agency For Science Technology & Research | 川崎病の診断及び治療 |
US20100190752A1 (en) | 2008-09-05 | 2010-07-29 | Gruenenthal Gmbh | Pharmaceutical Combination |
AU2009296457A1 (en) | 2008-09-27 | 2010-04-01 | Taraxos Inc. | Topical formulations for treatment of neuropathy |
CN105330603A (zh) | 2008-10-08 | 2016-02-17 | 凯飞药业公司 | Gaba偶联物及其使用方法 |
AU2014364647A1 (en) | 2013-12-17 | 2016-06-23 | Laboratorios Del Dr. Esteve, S.A. | Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) and Sigma receptor ligands combinations |
MA39146A1 (fr) * | 2013-12-17 | 2017-11-30 | Esteve Labor Dr | Combinaisons de gabapentanoïdes et de ligands des récepteurs sigma |
CA2951987C (en) | 2014-06-16 | 2017-10-24 | Farmaceuticos Rayere, S.A. | Pharmaceutical composition that combines an anticonvulsant and a nicotinic acid derivative |
MX2015016589A (es) | 2015-12-02 | 2017-06-01 | Samuel CHAIT AUERBACH Jaime | Composicion oral veterinaria con gabapentina. |
US10874626B2 (en) * | 2016-04-07 | 2020-12-29 | Nevakar Inc. | Formulation for use in a method of treatment of pain |
WO2017200700A1 (en) * | 2016-05-16 | 2017-11-23 | PixarBio Corporation | Methods for treating incisional pain |
WO2019067768A2 (en) * | 2017-09-28 | 2019-04-04 | Nevakar, Inc. | FIXED DOSE COMBINATION FORMULATIONS FOR THE TREATMENT OF PAIN |
EP3691748A4 (en) | 2017-10-03 | 2021-07-07 | Nevakar, Inc | ACETAMINOPHEN-PREGABALIN COMBINATIONS AND METHODS OF TREATMENT OF PAIN |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4694010A (en) | 1985-08-16 | 1987-09-15 | New York University | Anticonvulsant compositions and method |
AU4078897A (en) * | 1996-08-23 | 1998-03-06 | Algos Pharmaceutical Corporation | Anticonvulsant containing composition for treating neuropathic pain |
AU8668598A (en) * | 1997-08-20 | 1999-03-08 | University Of Oklahoma, The | Gaba analogs to prevent and treat gastrointestinal damage |
ATE311867T1 (de) * | 1997-09-08 | 2005-12-15 | Warner Lambert Co | Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen |
-
2000
- 2000-01-27 WO PCT/US2000/002080 patent/WO2000053225A1/en not_active Application Discontinuation
- 2000-01-27 AU AU32166/00A patent/AU3216600A/en not_active Abandoned
- 2000-01-27 US US09/936,394 patent/US6451857B1/en not_active Expired - Fee Related
- 2000-01-27 EP EP00909998A patent/EP1161263A1/en not_active Ceased
- 2000-01-27 JP JP2000603714A patent/JP2002538221A/ja not_active Withdrawn
- 2000-01-27 BR BR0008847-1A patent/BR0008847A/pt not_active IP Right Cessation
- 2000-01-27 CA CA002359485A patent/CA2359485A1/en not_active Abandoned
- 2000-02-23 AR ARP000100763A patent/AR022723A1/es unknown
- 2000-03-08 PE PE2000000204A patent/PE20001558A1/es not_active Application Discontinuation
- 2000-03-08 UY UY26052A patent/UY26052A1/es not_active Application Discontinuation
- 2000-03-08 CO CO00016924A patent/CO5150189A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CO5150189A1 (es) | 2002-04-29 |
EP1161263A1 (en) | 2001-12-12 |
JP2002538221A (ja) | 2002-11-12 |
PE20001558A1 (es) | 2001-01-28 |
US6451857B1 (en) | 2002-09-17 |
CA2359485A1 (en) | 2000-09-14 |
AR022723A1 (es) | 2002-09-04 |
BR0008847A (pt) | 2001-12-26 |
AU3216600A (en) | 2000-09-28 |
WO2000053225A1 (en) | 2000-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY26052A1 (es) | Composiciones analgesicas que comprenden compuestos antiepilepticos y metodos para usarlas | |
CU23226B7 (es) | COMPOSICIONES ANALGéSICAS QUE COMPRENDEN COMPUESTOS ANTI-EPILéPTICOS Y ANTINFLAMATORIOS NO ESTEROIDEOS | |
BR9909903A (pt) | Eficácia máxima de substâncias usadas para melhorar a saúde e bem-estar | |
CL2004000452A1 (es) | Uso de un compuesto antiepileptico que contiene propiedades de alivio del dolor y dos o mas compuestos del grupo formado por antagonista del nmda selectivos de subtipo, analgesicos, nsaid, y combinaciones de ellos, para la preparacion de un medicamen | |
SV2002000377A (es) | Una composicion farmaceutica para el tratamiento del dolor agudo, cronico y/o el dolor neuropatico y las migrañas pc10787/20150/bb | |
ES2177084T3 (es) | Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso. | |
DE60322436D1 (de) | Verabreichung von capsaicinoiden | |
AR044007A1 (es) | Metodos para el tratamiento de la enfermedad de parkinson | |
AR022252A1 (es) | Composicion de administracion oral. | |
AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
AR074313A1 (es) | Metodo para tratar o prevenir la trombosis utilizando etexilato de dabigatran o una sal del mismo. uso. kit | |
EA200870469A1 (ru) | Новые, содержащие нимесулид, фармацевтические композиции с низкой дозой, их получение и применение | |
IS6558A (is) | Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni | |
DE602004020494D1 (de) | Analgetische verbindungen, deren synthese und pharmazeutische zusammensetzungen, die diese enthalten | |
CO5190664A1 (es) | Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2 | |
AR030957A1 (es) | Composiciones de analgesico y glucosamina | |
EA201170784A1 (ru) | Гранулы тамсулозина для фиксированной комбинации | |
ECSP003378A (es) | Composiciones analgesicas que comprenden compuestos antiepilepticos y metodos para usarlas | |
RU2002129356A (ru) | Комбинация лекарственных средств для лечения головной боли, содержащая нестероидное противовоспалительное лекарственное средство | |
AR027677A1 (es) | Una composicion farmaceutica terapeutica que comprende camptotecina y ciclofosfamida para el tratamiento del cancer | |
FR2809725B1 (fr) | Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant | |
EA200100223A3 (ru) | Воднодисперсная лекарственная форма ивермектина для лечения экто- и эндопаразитозов | |
KR20230090186A (ko) | 파라세타몰 및 나프록센을 포함하는 약제학적 복합제제 | |
EA202092944A1 (ru) | Применение пероральных распадающихся таблеток рилузола для лечения заболеваний | |
AR124587A1 (es) | Métodos y composiciones para la administración rápida de terapias anticonvulsivas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20091202 |